A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy.
Nat Commun
; 12(1): 2768, 2021 05 13.
Article
in En
| MEDLINE
| ID: mdl-33986267
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Recombinant Fusion Proteins
/
Prodrugs
/
Interleukin-2
/
CD8-Positive T-Lymphocytes
/
Neoplasms
/
Antineoplastic Agents
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: